U.S. Food Stock News

NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic Evolut TAVR Trial Win May Recast Growth And Risk Profile

Medtronic (NYSE:MDT) reported that its Evolut transcatheter aortic valve achieved superior clinical outcomes compared with Edwards's Sapien valve in a large head to head TAVR trial. The three year study showed better haemodynamic performance and lower thrombosis rates for Evolut, including in patients with small annuli. The findings point to a potential shift in TAVR market share and could influence physician choice and future regulatory and hospital adoption. For a company like Medtronic,...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

Assessing Whether KLA (KLAC) Still Looks Overvalued After Its Strong Recent Share Price Run

Recent performance snapshot for KLA (KLAC) KLA (KLAC) has been on many watchlists after a strong run over the past year. The stock’s recent returns and current valuation metrics are drawing fresh attention from investors assessing semiconductor exposure. See our latest analysis for KLA. At a share price of $1,921.71, KLA’s recent momentum is strong, with a 90 day share price return of 26.05% and a very large 5 year total shareholder return. This suggests investors have been steadily re-rating...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

A Look At Gorilla Technology Group (GRRR) Valuation After Mixed Q1 2026 Earnings Results

Gorilla Technology Group (GRRR) just released Q1 2026 results, reporting sales of US$28.23 million compared with US$18.26 million a year earlier, alongside a wider net loss of US$36.96 million. See our latest analysis for Gorilla Technology Group. The Q1 2026 earnings release has come alongside sharp share price momentum, with a 1-day share price return of 15.45% and a 90-day share price return of 73.27%, while the 1-year total shareholder return stands at 17.84%. This suggests recent...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is It Too Late To Consider Eli Lilly (LLY) After A 51% One-Year Rally?

Investors may be wondering if Eli Lilly at around US$1,105 per share is still priced for opportunity or if it already reflects the market's optimism about its future. The stock has returned 3.8% over the past week, 29.8% over the last month, 2.3% year to date, and 50.9% over the past year. This naturally raises questions about how much potential or risk is now reflected in the price. These moves are occurring against a backdrop of ongoing attention on Eli Lilly's drug portfolio and pipeline,...
NYSE:WCN
NYSE:WCNCommercial Services

A Look At Waste Connections (WCN) Valuation After Recent Share Price Weakness

What Waste Connections stock’s recent slide means for investors Waste Connections (WCN) has drawn attention after its stock declined about 9% over the past month and roughly 13% over the past 3 months, prompting investors to reassess expectations. See our latest analysis for Waste Connections. At a share price of $149.02, Waste Connections is down 14.42% on a year to date share price basis and its 1 year total shareholder return has declined 23.77%, even though the 5 year total shareholder...
NYSE:DOW
NYSE:DOWChemicals

Do Dow’s Nuclear Power Plans Reframe Its Capital Discipline Narrative for (DOW) Investors?

Earlier in May 2026, Univar Solutions B.V. expanded its long-standing partnership with Dow to distribute Dow’s silicone additives for plastics and composites across EMEA, while Dow and X-energy received a Finding of No Significant Impact from the U.S. Nuclear Regulatory Commission for their proposed advanced nuclear project in Seadrift, Texas. Together, these moves broaden Dow’s access to specialty materials customers and progress its plans for low-carbon industrial power and steam at a...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

A Look At Crocs (CROX) Valuation After Recent Share Price Strength

Why Crocs (CROX) is on investors’ radar Crocs (CROX) has quietly put together a period of solid share price gains, with the stock up about 7% over the past week, 19% over the past month, and 31% in the past 3 months. See our latest analysis for Crocs. Against this backdrop, Crocs’ recent momentum stands out, with a 30.8% 90 day share price return and a 16.3% 1 year total shareholder return pointing to steadily improving sentiment rather than a short lived spike. If you are comparing Crocs...
NYSE:MMM
NYSE:MMMIndustrials

Australian PFAS Lawsuit Tests 3M Valuation And Long Term Risk Profile

The Australian government has filed a lawsuit against 3M (NYSE:MMM) over PFAS "forever chemicals" contamination. The case seeks compensation for environmental and health impacts that authorities link to historical PFAS use. This is one of the first major PFAS actions against 3M outside the US, adding to its global legal exposure. The lawsuit comes at a time when 3M shares trade around $153.13, with the stock up 6.4% over the past month and 5.2% over the past year. Investors now have a fresh...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Assessing Cohu (COHU) Valuation After New Diamondx Orders Linked To AI Data Center Demand

Why Cohu’s Diamondx Orders Matter for AI Data Center Exposure Cohu (COHU) recently reported multiple orders worth about US$5 million for its Diamondx platform, tied to next generation gallium nitride power devices used in AI data center power architectures. See our latest analysis for Cohu. At a share price of US$52.75, Cohu has seen a sharp 74.67% 90 day share price return and a very strong 209.02% 1 year total shareholder return, which suggests that momentum has been building as investors...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Valuation Check After Powerful Recent Share Price Momentum

Bandwidth stock reacts to strong recent performance Bandwidth (BAND) has drawn fresh attention after a sharp move in its share price, with the stock up 12.7% over the past day and posting strong gains over the past month and past 3 months. See our latest analysis for Bandwidth. Looking beyond the latest swing, Bandwidth’s recent 30 day share price return of 168.47% and year to date share price return of 356.89% sit alongside a 3 year total shareholder return of 436.94%. This points to...
NYSE:OKE
NYSE:OKEOil and Gas

Assessing ONEOK (OKE) Valuation After Recent Share Price Weakness

What ONEOK’s Recent Trading Tells You About the Stock ONEOK (OKE) has seen its stock slide about 6% over the past month, even as its total return over the past 3 years sits well above a multiple of 7x, putting recent moves in context. See our latest analysis for ONEOK. The recent 1-day share price return of down 3.54% and 7-day share price return of down 10.73% contrast with a year-to-date share price return of 12.91% and a 3-year total shareholder return of 66.76%. This suggests that...
NYSE:ADM
NYSE:ADMFood

Assessing Archer-Daniels-Midland (NYSE:ADM) Valuation After Strong Recent Share Price Momentum

Recent performance snapshot With no single headline event driving recent trading, Archer-Daniels-Midland (ADM) has drawn interest as the stock’s recent moves contrast with its longer track record of total returns and its current valuation metrics. See our latest analysis for Archer-Daniels-Midland. ADM’s recent share price move to around US$79.78 comes after a strong run, with a 30 day share price return of 7.42% and a 1 year total shareholder return of 70.48%. This suggests that momentum has...
NasdaqGM:GDS
NasdaqGM:GDSIT

GDS Holdings Refreshes Audit Oversight As Investors Weigh Governance Risks

GDS Holdings (NasdaqGM:GDS) announced that long-serving Chairman Mr. Lim Ah Doo has resigned from the board. Ms. Hua (Kathy) Chen has been appointed as an independent director and Chair of the Audit Committee, taking over key governance responsibilities. The leadership transition marks a change in board and committee oversight after Mr. Lim’s 11-year contribution to the company’s corporate governance. For investors watching NasdaqGM:GDS, this governance update comes with the stock at a...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Ocular Therapeutix (OCUL) Valuation Check After Recent Trading And AXPAXLI Growth Expectations

Ocular Therapeutix (OCUL) has been drawing fresh attention after recent trading moves, with the stock closing at US$9.01 and posting mixed short term returns across the past week, month and past 3 months. See our latest analysis for Ocular Therapeutix. Recent trading puts that US$9.01 share price in context, with short term share price momentum firming over the past week but still weaker year to date, while longer term total shareholder returns over one and three years remain positive. If you...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel’s US$3.3b India Plant Raises Questions On Growth And Valuation

Intel (NasdaqGS:INTC) and 3DGS plan to build a substrate manufacturing plant in Odisha, India, with a joint investment of US$3.3b. The project is intended to support growth in India's semiconductor ecosystem and expand regional supply chain capacity. Government incentives in India are a key factor in the decision to locate the facility in Odisha. The plant is expected to create high skilled jobs and contribute to India's chip manufacturing ambitions. For Intel, a major global semiconductor...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

A Look At NextDecade (NEXT) Valuation After Citi Initiates Coverage With A Buy Rating

Citi’s initiation of coverage on NextDecade (NEXT) has put fresh attention on the stock, as investors weigh the firm’s view against approaching milestones at the company’s Rio Grande LNG project in Texas. See our latest analysis for NextDecade. At a share price of US$7.91, NextDecade has seen short term momentum cool with a 7 day share price return that declined 6.5%, but the 90 day share price return of 46.75% and 5 year total shareholder return of 224.18% point to a stock where sentiment...
NYSE:GE
NYSE:GEAerospace & Defense

A Look At General Electric’s Valuation As New Air Force Engine Contract And Strong Q1 2026 Results Lift Optimism

General Electric (GE) is back in focus after GE Aerospace secured a U.S. Air Force contract to advance its GE426 engine for the Autonomous Collaborative Platform program, while also reporting robust Q1 2026 results and reaffirmed guidance. See our latest analysis for General Electric. The latest U.S. Air Force engine contract and solid Q1 2026 update appear to be feeding into renewed optimism, with General Electric's 7 day share price return of 6.9% and 30 day share price return of 14.2%...
NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Share Rebound Signalling A Possible Valuation Opportunity Now

Wondering whether Estée Lauder Companies at around US$88.95 is offering fair value or an opportunity? This article walks through what the current price might be telling you. The stock is up 0.7% over the past week and 17.5% over the past month. However, it remains down 16.7% year to date, with a 34.8% gain over 1 year but declines of 50.0% over 3 years and 68.4% over 5 years. The recent rebound therefore sits against a much weaker longer-term picture. Recent headlines around Estée Lauder...
NYSE:LEU
NYSE:LEUOil and Gas

A Look At Centrus Energy (LEU) Valuation After New Federal Funding And HALEU Expansion Plans

Centrus Energy (LEU) has drawn fresh investor attention after securing significant federal funding and outlining a substantial expansion of its centrifuge manufacturing plant, reinforcing its role as the only licensed HALEU producer in the Western world. See our latest analysis for Centrus Energy. The federal funding and HALEU expansion news come after a period where the share price has fallen 33% year to date to US$182.47, even as the 1 year total shareholder return is 43.77% and the 5 year...
NYSE:TOST
NYSE:TOSTDiversified Financial

Is Toast (TOST) Offering Value After Recent Share Price Rebound?

Wondering if Toast's current share price offers value or just extra risk? This article walks through what the numbers say so you can judge whether the stock fits your approach. Toast shares closed at US$26.03, with the stock up 12.4% over the last 7 days, but down 9.0% over 30 days, 23.5% year to date, and 38.3% over the past year, while still showing a 23.5% gain over 3 years. Recent headlines have focused on Toast as a listed point of sale and payments platform for restaurants,...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

Is It Too Late To Revisit F5 (FFIV) After Its Strong Year To Date Rally?

If you are wondering whether F5 at around US$383 per share offers fair value or is pricing in too much optimism, you are not alone. The stock is down 2.6% over the last week, but up 16.9% over the past month, 49.4% year to date, 34.4% over the last year, 161.3% over three years and 103.1% over five years, which naturally raises questions about what is now baked into the price. Recent coverage has focused on F5's role in application security and multi cloud networking, as investors weigh how...
NYSE:FSS
NYSE:FSSMachinery

Assessing Federal Signal (FSS) Valuation After Recent Share Price Pullback

Federal Signal (FSS) is back on investor radars after recent share price softness, with the stock down about 12% over the past month and roughly 8% over the past 3 months. See our latest analysis for Federal Signal. At a share price of $106.70, the stock has given up some ground recently, with the 7 day share price return down 5.25% and the 30 day share price return down 12.17%. However, the 1 year total shareholder return of 14% and 5 year total shareholder return of 155.39% still point to a...
NYSE:UBER
NYSE:UBERTransportation

Uber Expands World Cup, Hotel And EV Push As Shares Look Undervalued

Uber Technologies (NYSE:UBER) has launched Uber Shuttle services for the FIFA World Cup, targeting large scale event transportation. The company has integrated with hotel platform Mews, enabling ride bookings at more than 15,000 hotels worldwide. Uber has entered an electric vehicle partnership with JSW Group in India to develop EVs tailored to local ride hailing needs. Uber Technologies, trading at about $70.4, is rolling out these initiatives while the stock is down 15.0% year to date and...
NasdaqCM:DUOT
NasdaqCM:DUOTSoftware

A Look At Duos Technologies Group (DUOT) Valuation As 2026 Revenue Outlook Is Reaffirmed And Visibility Rises

Duos Technologies Group (DUOT) has reaffirmed its expectation for 2026 revenue to exceed US$50 million and is preparing to present at the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026. See our latest analysis for Duos Technologies Group. The reaffirmed 2026 revenue outlook and upcoming Craig Hallum conference appearance come after a sharp 30 day share price return of 63.64% and a 1 year total shareholder return of 76.47%. This suggests momentum has been building...